• Name: Retatrutide – 40mg vial 
• Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Molecular Weight: ~4731–4845 g/mol
• CAS Number: 2381089‑83‑2
• COA (certificate of analysis) provided: Retatrutide Purity Report 99.8_ HPLC
• Purity: 99.8% HPLC

• Name: 5-Amino-1MQ – 50mg vial
• Sequence: is a small molecule, not a peptide, has no amino‑acid sequence.
• Length: has no amino‑acids
• CAS Number: 42464‑96‑0
• Molecular Formula: C₁₀H₁₁N₂I
• Molecular Weight: ≈286.11 g/mol
• COA (certificate of analysis) provided: 5 Amino 1 MQ COA 99.15%
• Purity: 99.15% HPLC

Retatrutide and 5-Amino-1MQ (5-amino-1-methylquinolinium) are frequently stacked in research and clinic protocols for enhanced fat loss, insulin sensitivity, and metabolic efficiency, with complementary mechanisms: retatrutide as a triple-agonist (GLP-1/GIP/glucagon) for appetite/energy control, and 5-Amino-1MQ as an NNMT inhibitor to boost NAD+ and mitochondrial fat oxidation.​

Why combine them

• Synergy: Retatrutide reduces caloric intake and shifts fuel to fat-burning, while 5-Amino-1MQ unlocks trapped fat stores by inhibiting NNMT (which normally slows metabolism via NAD+ depletion) and amplifies muscle energy use.​

• Outcomes in discussions: Faster visceral fat loss, better muscle preservation, improved endurance, and metabolic flexibility without excessive GI side effects from retatrutide alone.​

• No formal trials: This is experimental; stacks appear in peptide clinics, social media, and expert talks but lack randomized human data.